Abstract
A $70-million-a-year program launched 7 years ago at the National Institutes of Health to help academic researchers move into industry-style drug discovery may soon be forced to scale back sharply.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献